Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A multicenter, prospective study

Clinical Infectious Diseases

Volumn 57, Issue 5, 2013, Pages 671-681

  Ogata, Masao ^a   Satou, Takako ^a   Kadota, Jun Ichi ^a   Saito, Noriyuki ^b   Yoshida, Takashi ^c   Okumura, Hirokazu ^c   Ueki, Toshimitsu ^d   Nagafuji, Koji ^e   Kako, Shinichi ^f   Uoshima, Nobuhiko ^g   Tsudo, Mitsuru ^h   Itamura, Hidekazu ⁱ   Fukuda, Takahiro ^j  

^a OITA UNIVERSITY HOSPITAL   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d NAGANO RED CROSS HOSPITAL   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^h OSAKA RED CROSS HOSPITAL   (Japan)

ⁱ SAGA UNIVERSITY   (Japan)

^j NATIONAL CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

allogeneic hematopoietic cell transplantation; HHV 6 encephalitis; HHV 6 reactivation; human herpesvirus 6; viral load

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BUSULFAN; FLUDARABINE; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HERPES SIMPLEX ENCEPHALITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 ENCEPHALITIS; INCIDENCE; INFECTION PREVENTION; LANGERHANS CELL HISTIOCYTOSIS; LYMPHOBLASTOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PLASMA CELL LEUKEMIA; PREVALENCE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYMPTOM; T CELL LEUKEMIA; VIRUS LOAD; VIRUS REACTIVATION; VIRUS STRAIN; WHOLE BODY RADIATION;

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION; HHV-6 ENCEPHALITIS; HHV-6 REACTIVATION; HUMAN HERPESVIRUS 6; VIRAL LOAD;

ADOLESCENT; ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; DNA, VIRAL; ENCEPHALITIS, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; VIRAL LOAD; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84881404243     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit358     Document Type: Article

References (26)

1. Adams MJ, Carstens EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Arch Virol 2012; 157:1411-22.
2. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40:932-40.
3. Ogata M, Kikuchi H, Satou T, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: Incidence and clinical significance. J Infect Dis 2006; 193:68-79.
4. Wang LR, Dong LJ, Zhang MJ, Lu DP. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:1031-7.
5. Zerr DM. Human herpesvirus 6 (HHV-6) disease in the setting of transplantation. Curr Opin Infect Dis 2012; 25:438-44.
6. Zerr DM, Boeckh M, Delaney C, et al. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18:1700-8.
7. Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006; 37:52-6.
8. OgataM, Satou T, Kawano R, et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2010; 45:129-36.
9. Fujimaki K, Mori T, Kida A, et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006; 84:432-7.
10. Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV-6. Neurology 2007; 69:156-65.
11. Muta T, Fukuda T, Harada M. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: A retrospective multicenter study. Bone Marrow Transplant 2009; 43:583-5.
12. Mori Y, Miyamoto T, Nagafuji K, et al. High incidence of human herpes virus 6-associated encephalitis/myelitis following a second unrelated cord blood transplantation. Biol Blood Marrow Transplant 2010; 16:1596-602.
13. Hill JA, Koo S, Guzman Suarez BB, et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: A cohort analysis. Biol Blood Marrow Transplant 2012; 18:1638-48.
14. Shimazu Y, Kondo T, Ishikawa T, Yamashita K, Takaori-Kondo A. Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis. Transpl Infect Dis 2013; 15:195-201.
15. Sakai R, Kanamori H, Motohashi K, et al. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:1389-94.
16. Ljungman P, de la Camara R, Cordonnier C, et al. European Conference on Infections in Leukemia. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008; 42:227-40.
17. Yamane A, Mori T, Suzuki S, et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13:100-6.
18. Ljungman P,Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111:774-81.
19. Zerr DM, Fann JR, Breiger D, et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011; 117:5243-9.
20. Giralt S, Ballen K, Rizzo D, et al. Reduced-intensity conditioning regimen workshop: Defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15:367-9.
21. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15:825-8.
22. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. BoneMarrow Transplant 2013; 48:452-8.
23. Yoshikawa T, Asano Y, Ihira M, et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: Clinical features and risk factors. J Infect Dis 2002; 185:847-53.
24. Hentrich M, Oruzio D, Jager G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005; 128:66-72.
25. Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. HHV-6 encephalitis in umbilical cord blood transplantation: A systematic review and meta-analysis. Bone Marrow Transplant 2013; 48: 574-80.
26. Flamand L, Gravel A, Boutolleau D, et al. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 2008; 46:2700-6.